Tranimul en es it fr

Tranimul Brand names, Tranimul Analogs

Tranimul Brand Names Mixture

  • No information avaliable

Tranimul Chemical_Formula


Tranimul RX_link

Tranimul fda sheet

Tranimul msds (material safety sheet)

Tranimul MSDS

Tranimul Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Tranimul Molecular Weight

284.74 g/mol

Tranimul Melting Point


Tranimul H2O Solubility

Slightly soluble (50 mg/L)

Tranimul State


Tranimul LogP


Tranimul Dosage Forms

Tablets; Injectable solution

Tranimul Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Tranimul Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Tranimul Absorption

Essentially complete, with a bioavailability of 93%.

Tranimul side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Tranimul Patient Information

Tranimul Organisms Affected

Humans and other mammals